Accelerating the future of human health and wellness
Accelagen is a leading Contract Research Organisation (CRO) headquartered in Australia that works with innovative clients across the globe to make a tangible impact on the future of human health and wellness.
Accelerating the future of human health and wellness
Accelagen is a leading, globally adept Contract Research Organisation (CRO) headquartered in Melbourne, Australia. With a combined 160+ years of delivered success, the Accelagen team’s experience varies widely across the health, wellness and disease spectrum. Additionally, we offer end-to-end services across Strategic Consultation, Clinical Trials, Regulatory Affairs, Biometrics and Medical, Safety & Pharmacovigilance.
Accelagen provides customised, flexible, agile and cost-effective clinical solutions to help big pharma and emerging biotech companies get their innovative treatments to patients and to market quickly. The Accelagen team adopts a collaborative approach to partnering with clients across the globe to make a tangible difference to the future of human health and wellness.
Elevating purpose and putting people first
What makes us different to other Contract Research Organisations (CRO) is our unique approach and process. We are guided by our purpose to co-create meaningful outcomes that positively impact the future of human health and wellness.
We start by understanding your story – where you are at in the journey and the broader context of the impact you hope to have. And, like time travellers, we jump ahead to a point in time where we can clearly see the desired outcomes where, with years of experience and expertise, we co-create a ‘reverse journey map’ roadmapping the best pathway, the right pathway to get there together. This means a bespoke and tailored strategic approach that ensures we’re offering the right skill sets, expertise and services and that your time and money is spent in the right places.
Lasting partnerships
Our focus is on building lasting partnerships and transparent relationships. Unlike typical contract research organisations (CROs), our projects are not a transaction. Rather, a true collaboration where we involve our experts along the entire journey from concept through to commercialisation.
Our people
Putting people first, our unique approach results in meaningful outcomes that have a tangible impact on the future of human health, co-created with you every step of the way. Our team consists of respected thought-leaders in their fields, with years of success and broad therapeutic and operational experience locally and internationally.
Our values
We are proud to live our values of passion, dedication, agility, integrity and care through the work we deliver and the culture we’ve created. Additionally, we aim to collaborate with like-minded teams to make a difference to the future of human health.
What we offer
Clinical Trial Management
Optimising your studies from initiation to completion. About Clinical Trial Management At Accelagen, we pride...
Strategic Consultation
Partnering clients through the process, from end to end. About Strategic Consultation At Accelagen, our...
Biometrics
Creating real-world use for high-quality data. About Biometrics Accelagen is proud to add our expertly-led...
Regulatory Affairs
Success is mapped alongside every strategic step we take. About Regulatory Affairs A deep understanding...
Testimonials
Testimonials
Latest news
Accelagen Staff Announcement: Amritha Vangur
Accelagen Staff Announcement: Amritha Vangur The Accelagen family is growing…again!...
Accelagen Staff Announcement: Suzanne Leong
Accelagen Staff Announcement: Suzanne Leong We are excited to formally...
Accelagen Staff Announcement: Sian Gilmour
Accelagen Staff Announcement: Sian Gilmour One of the things we...
Latest news
Welcoming our new Business Planning and Analysis Manager
Welcoming our new Business Planning and Analysis Manager Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education, an ASX top 100 company, where he excelled in financial reporting and business analysis. […]
Read More
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results Local CRO, Accelagen, attracts innovative European drug and antibody developers to trial in Australian market Engaged by world-renowned European clients and collaborators, Memo Therapeutics AG (“MTx”) based in Switzerland, and Vakzine Projekt Management GmbH (VPM) based […]
Read More
Accelagen Staff Announcement: Amritha Vangur
Accelagen Staff Announcement: Amritha Vangur The Accelagen family is growing…again! Today we are thrilled to announce that Amritha Vangur has rejoined our team as Clinical Research Associate. Amritha first worked at Accelagen in 2019. The company was in its infancy at the time, with a small, tight-knit team. Shortly after joining, Amritha travelled overseas and […]
Read More
"Helping you achieve successful approval We approached Accelagen as we needed additional resources to complete our project. As a result of their assistance and advice, we were able to complete the necessary tasks required to achieve a successful marketing approval.